Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13

Loyd V Allen, Claudia C Okeke
International Journal of Pharmaceutical Compounding 2009, 13 (3): 234-8
A compounding facility, including the staff, bears the responsibility of ensuring that any potential soucre of contamination has been considered, properly addressed, and documented. Therefore, the design of the compounding facility must consider the (1)potential for airborne contamination, (2)work flow, (3)efficiency, and (4)personnel comfort. The understanding of a critical site, which is any location that is exposed and can allow intrusion of microorganisms and/or foreign matter, and the nature of the critical site and exposure is paramount in the compounding of sterile preparations. This means that not only the design of the facility must be considered but standard operating procedures must be in place for personnel, and those procedures must be strictly adhered to. This article emphasizes the improtance of considering the critical site during compounding procedures, the design and rationale supporting the facility, and operational activities surrounding active compounding.

Full Text Links

Find Full Text Links for this Article


You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"